CCL

Összesen 3 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM038593
Első szerző:Cervera, Ricard
Cím:Antiphospholipid syndrome : clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients / Ricard Cervera, Jean-Charles Piette, Josep Font, Munther A. Khamashta, Yehuda Shoenfeld, Maria Teresa Camps, Soren Jacobsen, Gabriella Lakos, Angela Tincani, Irene Kontopoulou-Griva, Mauro Galeazzi, Pier Luigi Meroni, Ronald H. W. M. Derksen, Philip G. de Groot, Erika Gromnica-Ihle, Marta Baleva, Marta Mosca, Stefano Bombardieri, Frédéric Houssiau, Jean-Christophe Gris, Isabelle Quéré, Eric Hachulla, Carlos Vasconcelos, Beate Roch, Antonio Fernández-Nebro, Marie-Claire Boffa, Graham R. V. Hughes, Miguel Ingelmo, Euro-Phospholipid Project Group
Dátum:2002
ISSN:0004-3591
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Arthritis And Rheumatism 46 : 4 (2002), p. 1019-1027. -
További szerzők:Piette, Jean-Charles Font, Josep Khamashta, Munther A. Shoenfeld, Yehuda Camps, Maria Teresa Jacobsen, Soren Lakos Gabriella (1963-) (laboratóriumi szakorvos, transzfúziológus, immunológus) Tincani, Angela Kontopoulou-Griva, Irene Galeazzi, Mauro Meroni, Pier Luigi Derksen, Ronald H. W. M. de Groot, Philip G. Gromnica-Ihle, Erika Baleva, Marta Mosca, Marta Bombardieri, Stefano Houssiau, Frédéric Gris, Jean-Christophe Quéré, Isabelle Hachulla, Eric Vasconcelos, Carlos Roch, Beate Fernández-Nebro, Antonio Boffa, Marie-Claire Hughes, Graham R. V. Ingelmo, Miguel Soltész Pál (1961-) (belgyógyász, kardiológus) Zeher Margit (1957-2018) (belgyógyász, allergológus és klinikai immunológus, reumatológus) Kiss Emese (1960-) (belgyógyász, immunológus) Euro-Phospholipid Project Group
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM034058
Első szerző:Ramos-Casals, Manuel
Cím:Sjögren syndrome associated with hepatitis C virus : a multicenter analysis of 137 cases / Ramos-Casals M., Loustaud-Ratti V., de Vita S., Zeher M., Bosch J. A., Toussirot E., Medina F., Rosas J., Anaya J. M., Font J., the SS-HCV Study Group
Dátum:2005
Megjegyzések:To define the clinical and immunologic pattern of expression of Sjögren syndrome (SS) associated with chronic hepatitis C virus (HCV) infection, we conducted a multicenter study aiming to collect a large number of patients with SS and HCV infection. Inclusion criteria were the fulfillment of at least 4 of the classification criteria for SS proposed by the European Community Study Group and repeated positive HCV serology, confirmed by recombinant immunoblot assay and/or detection of serum HCV-RNA by polymerase chain reaction. One hundred thirty-seven patients were included (104 female and 33 male; mean age, 65 yr). Seventy-nine (58%) patients presented a systemic process with diverse extraglandular manifestations, with articular involvement (44%), vasculitis (20%), and neuropathy (16%) being the most frequent features observed. The main immunologic features were antinuclear antibodies (65%), hypocomplementemia (51%), and cryoglobulinemia (50%). Cryoglobulins were associated with a higher frequency of cutaneous vasculitis, rheumatoid factor, and hypocomplementemia. Thirty-two (23%) patients had positive anti-Ro/SS-A and/or anti-La/SS-B antibodies; these patients were predominantly women and had a higher prevalence of some extraglandular features and a lower frequency of liver involvement. Nineteen (14%) patients developed neoplasia, with hematologic neoplasia (8 cases) and hepatocellular carcinoma (6 cases) being the most frequent types. Eighty-five percent of SS-HCV patients also fulfilled the recently proposed 2002 classification criteria for SS. In conclusion, HCV-associated SS is indistinguishable in most cases from the primary form using the most recent set of classification criteria. Chronic HCV infection should be considered an exclusion criterion for the classification of primary SS, not because it mimics primary SS, but because the virus may be implicated in the development of SS in a specific subset of patients. We propose the term "SS secondary to HCV" when these patients fulfill the 2002 classification criteria for SS.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Medicine. - 84 : 2 (2005), p. 81-89. -
További szerzők:Loustaud-Ratti, Veronique Vita, Salvatore de Zeher Margit (1957-2018) (belgyógyász, allergológus és klinikai immunológus, reumatológus) Bosch, Jose-Angel Toussirot, Eric Medina, Francisco Rosas, José Anaya, Juan-Manuel Font, Josep The SS-HCV Study Group
Internet cím:Szerző által megadott URL
Borító:

3.

001-es BibID:BIBFORM034076
Első szerző:Ramos-Casals, Manuel
Cím:Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection / Ramos-Casals M., la Civita L., de Vita S., Solans R., Luppi M., Medina F., Caramaschi P., Fadda P., de Marchi G., Lopez-Guillermo A., Font J., The SS-HCV Study Group
Dátum:2007
Megjegyzések:OBJECTIVE: To characterize the clinical and immunologic patterns of expression, response to therapy, and outcome of patients with Sjögren's syndrome (SS) and associated hepatitis C virus (HCV) infection who developed B cell lymphoma. METHODS: Various international reference centers constituted a multicenter study group with the purpose of creating a registry of patients with SS-HCV who developed B cell lymphoma. A protocol form was used to record the main characteristics of SS, chronic HCV infection, and B cell lymphoma. RESULTS: Twenty-five patients with SS-HCV with B cell lymphoma were included in the registry. There were 22 (88%) women and 3 (12%) men (mean age 55, 58, and 61 years at SS, HCV infection, and lymphoma diagnosis, respectively). The main extraglandular SS manifestations were cutaneous vasculitis in 15 (60%) patients and peripheral neuropathy in 12 (48%); the main immunologic features were positive rheumatoid factor (RF) in 24 (96%) and type II cryoglobulins in 20 (80%). The main histologic subtypes were mucosa-associated lymphoid tissue (MALT) lymphoma in 11 (44%) patients, diffuse large B cell lymphoma in 6 (24%), and follicular center cell lymphoma in 6 (24%). Fifteen (60%) patients had an extranodal primary location, most frequently in the parotid gland (5 patients), liver (4 patients), and stomach (4 patients). Twelve (52%) of 23 patients died after a median followup from the time of lymphoma diagnosis of 4 years, with lymphoma progression being the most frequent cause of death. Survival differed significantly between the main types of B cell lymphoma. CONCLUSION: Patients with SS-HCV and B cell lymphoma are clinically characterized by a high frequency of parotid enlargement and vasculitis, an immunologic pattern overwhelmingly dominated by the presence of RF and mixed type II cryoglobulins, a predominance of MALT lymphomas, and an elevated frequency of primary extranodal involvement in organs in which HCV replicates (exocrine glands, liver, and stomach).
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:Arthritis and Rheumatism. - 57 : 1 (2007), p. 161-170. -
További szerzők:la Civita L., Vita, Salvatore de Solans, Roser Luppi, M. Medina, Francisco Caramaschi, Paola Fadda, P. de Marchi, G. Lopez-Guillermo, A. Font, Josep Zeher Margit (1957-2018) (belgyógyász, allergológus és klinikai immunológus, reumatológus) The SS-HCV Study Group
Internet cím:Intézményi repozitóriumban (DEA) tárolt változat
DOI
Borító:
Rekordok letöltése1